Targeting XRCC1 deficiency in breast cancer for personalized therapy.

Abstract:

:XRCC1 is a key component of DNA base excision repair, single strand break repair, and backup nonhomologous end-joining pathway. XRCC1 (X-ray repair cross-complementing gene 1) deficiency promotes genomic instability, increases cancer risk, and may have clinical application in breast cancer. We investigated XRCC1 expression in early breast cancers (n = 1,297) and validated in an independent cohort of estrogen receptor (ER)-α-negative breast cancers (n = 281). Preclinically, we evaluated XRCC1-deficient and -proficient Chinese hamster and human cancer cells for synthetic lethality application using double-strand break (DSB) repair inhibitors [KU55933 (ataxia telangectasia-mutated; ATM inhibitor) and NU7441 (DNA-PKcs inhibitor)]. In breast cancer, loss of XRCC1 (16%) was associated with high grade (P < 0.0001), loss of hormone receptors (P < 0.0001), triple-negative (P < 0.0001), and basal-like phenotypes (P = 0.001). Loss of XRCC1 was associated with a two-fold increase in risk of death (P < 0.0001) and independently with poor outcome (P < 0.0001). Preclinically, KU55933 [2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one] and NU7441 [8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one] were synthetically lethal in XRCC1-deficient compared with proficient cells as evidenced by hypersensitivity to DSB repair inhibitors, accumulation of DNA DSBs, G2-M cell-cycle arrest, and induction of apoptosis. This is the first study to show that XRCC1 deficiency in breast cancer results in an aggressive phenotype and that XRCC1 deficiency could also be exploited for a novel synthetic lethality application using DSB repair inhibitors. Cancer Res; 73(5); 1621-34. ©2012 AACR.

journal_name

Cancer Res

journal_title

Cancer research

authors

Sultana R,Abdel-Fatah T,Abbotts R,Hawkes C,Albarakati N,Seedhouse C,Ball G,Chan S,Rakha EA,Ellis IO,Madhusudan S

doi

10.1158/0008-5472.CAN-12-2929

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

1621-34

issue

5

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-12-2929

journal_volume

73

pub_type

杂志文章
  • MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.

    abstract::Despite favorable responses to initial therapy, small-cell lung cancer (SCLC) relapse occurs within a year and exhibits resistance to multiple drugs. Because of limited accessibility of patient tissues for research purposes, SCLC patient-derived xenografts (PDX) have provided the best opportunity to address this limit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-2874

    authors: Tripathi SC,Fahrmann JF,Celiktas M,Aguilar M,Marini KD,Jolly MK,Katayama H,Wang H,Murage EN,Dennison JB,Watkins DN,Levine H,Ostrin EJ,Taguchi A,Hanash SM

    更新日期:2017-08-15 00:00:00

  • A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.

    abstract::Antineoplastic drug resistance is a major obstacle to improved treatment of most adult cancers in humans. Novobiocin, an antibacterial agent which inhibits the eukaryotic topoisomerase II enzyme, increases the cytotoxicity of several alkylating agents in vitro by the formation of lethal DNA-DNA interstrand cross-links...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Eder JP,Wheeler CA,Teicher BA,Schnipper LE

    更新日期:1991-01-15 00:00:00

  • Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.

    abstract::Matrix metalloproteinase-2 (MMP-2) expression is often up-regulated in advanced cancers and known to play an important role in tumor angiogenesis. We previously showed that adenoviral-mediated delivery of siRNA for MMP-2 (Ad-MMP-2-Si) inhibited lung cancer growth, angiogenesis, and metastasis. In this study, we invest...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6612

    authors: Chetty C,Lakka SS,Bhoopathi P,Kunigal S,Geiss R,Rao JS

    更新日期:2008-06-15 00:00:00

  • Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.

    abstract::The N-myc gene is transiently expressed during normal embryonic development and abnormally expressed in several tumors of neuroendocrine origin. Little is known of the function of the N-myc gene product in either normal or neoplastic tissue. We utilized synthetic antisense oligodeoxynucleotides to specifically inhibit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rosolen A,Whitesell L,Ikegaki N,Kennett RH,Neckers LM

    更新日期:1990-10-01 00:00:00

  • In vitro and in vivo cytotoxicity of an anti-osteosarcoma immunotoxin containing pokeweed antiviral protein.

    abstract::Successful treatment of many patients with osteosarcoma requires more effective chemotherapy. Since new agents are needed, we have developed an immunotoxin using TP-3, an IgG2b mAb which recognizes human and canine osteosarcomas and budding capillaries of tumors. The plant hemitoxin, pokeweed antiviral protein (PAP), ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Anderson PM,Meyers DE,Hasz DE,Covalcuic K,Saltzman D,Khanna C,Uckun FM

    更新日期:1995-03-15 00:00:00

  • Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization.

    abstract::beta 1-4 N-acetylglucosaminyltransferase (GnT-III) catalyzes the formation of bisecting N-acetylglucosamine (GlcNAc) in the biosynthesis of N-linked oligosaccharides. To examine the effect of bisecting GlcNAc on the natural killer (NK) cytotoxicity, the GnT-111 gene was introduced into NK-sensitive K562 cells that hav...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshimura M,Ihara Y,Ohnishi A,Ijuhin N,Nishiura T,Kanakura Y,Matsuzawa Y,Taniguchi N

    更新日期:1996-01-15 00:00:00

  • Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.

    abstract::The microenvironment of rapidly growing tumors is associated with increased energy demand and diminished vascular supply, resulting in focal areas of prominent hypoxia. A number of hypoxia-responsive genes have been associated with growing tumors, and here we demonstrate that the multidrug resistance (MDR1) gene produ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Comerford KM,Wallace TJ,Karhausen J,Louis NA,Montalto MC,Colgan SP

    更新日期:2002-06-15 00:00:00

  • Targeting Obesity-Induced Macrophages during Preneoplastic Growth Promotes Mammary Epithelial Stem/Progenitor Activity, DNA Damage, and Tumor Formation.

    abstract::Obesity enhances breast cancer risk in postmenopausal women and premenopausal women with genetic or familial risk factors. We have shown previously that within breast tissue, obesity increases macrophage-driven inflammation and promotes expansion of luminal epithelial cell populations that are hypothesized to be the c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0789

    authors: Chamberlin T,Clack M,Silvers C,Kuziel G,Thompson V,Johnson H,Arendt LM

    更新日期:2020-10-15 00:00:00

  • Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL.

    abstract::Paclitaxel is a standard-of-care chemotherapy for breast cancer, despite the increasing recognition of its poor effectiveness in the treatment of patients with advanced disease. Here, we report that adenovirus-type 5 E1A-mediated elevation of the miRNA-processing enzyme Dicer is sufficient to enhance paclitaxel sensit...

    journal_title:Cancer research

    pub_type: 杂志文章,收录出版

    doi:10.1158/0008-5472.CAN-15-2555

    authors: Chang TY,Chen HA,Chiu CF,Chang YW,Kuo TC,Tseng PC,Wang W,Hung MC,Su JL

    更新日期:2016-07-01 00:00:00

  • p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.

    abstract::Fifty-eight skin biopsies and three primary internal tumors from patients affected by the rare hereditary disease xeroderma pigmentosum (XP) were studied by an improved PCR-single strand conformation polymorphism analysis to detect the mutations of the tumor suppressor gene p53. The results from cutaneous XP tumors, i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Giglia G,Dumaz N,Drougard C,Avril MF,Daya-Grosjean L,Sarasin A

    更新日期:1998-10-01 00:00:00

  • Phenol-soluble nonhistone chromatin proteins in chronic lymphocytic leukemia.

    abstract::The altered gene expression seen in cancer could relate to differences in nonhistone chromatin proteins between normal and malignant tumor cells. Phenol-soluble nonhistone chromatin proteins were isolated from human normal and leukemic (chronic lymphocytic leukemia) B-cells, as well as long-term cultured human B-lymph...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jones CA,Hesse L,Muzik H,Jerry LM

    更新日期:1984-05-01 00:00:00

  • Changes in transfer RNA's in human malignant trophoblastic cells (BeWo line).

    abstract::Ten aminoacyl transfer RNA's prepared from human malignant trophoblastic cells (BeWo line) were compared with the corresponding aminoacyl transfer RNA's from normal human chorionic tissue by cochromatography on a RPC-5 column. Phenylalanyl transfer RNA (Phe-tRNA) of BeWo cells had, in addition to the single species of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kuchino Y,Borek E

    更新日期:1976-08-01 00:00:00

  • Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells.

    abstract::Calcium is universally required for cell growth and proliferation. Calmodulin is the main intracellular receptor for calcium. Although calcium and calmodulin are well known to be required for cell cycle regulation, the target pathways for their action remain poorly defined. Potential targets include the calcium/calmod...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0271

    authors: Rodriguez-Mora OG,LaHair MM,McCubrey JA,Franklin RA

    更新日期:2005-06-15 00:00:00

  • Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.

    abstract::Serological identification of tumor antigens by cDNA expression cloning is a technique used to isolate cDNAs encoding tumor antigens that are recognized by IgG antibodies in sera from cancer patients. It is also useful for the isolation of tumor antigens recognized by T cells. We applied this method to identify melano...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kiniwa Y,Fujita T,Akada M,Ito K,Shofuda T,Suzuki Y,Yamamoto A,Saida T,Kawakami Y

    更新日期:2001-11-01 00:00:00

  • Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.

    abstract::Membrane-type matrix metalloproteinases (MT-MMP) constitute a subfamily of six distinct membrane-associated MMPs. Although the contribution of MT1-MMP during different steps of cancer progression has been well documented, the significance of other MT-MMPs is rather unknown. We have investigated the involvement of MT4-...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3012

    authors: Chabottaux V,Sounni NE,Pennington CJ,English WR,van den Brûle F,Blacher S,Gilles C,Munaut C,Maquoi E,Lopez-Otin C,Murphy G,Edwards DR,Foidart JM,Noël A

    更新日期:2006-05-15 00:00:00

  • Enhancement of X-ray cell killing in cultured mammalian cells by the protein phosphatase inhibitor calyculin A.

    abstract::Effects of calyculin A, a potent inhibitor of protein phosphatases 1 and 2A, on X-ray cell killing and chromatin structure were studied using cultured mammalian cells (BHK21). Calyculin A at concentrations of 2.5-20 nM enhanced X-ray cell killing when exponentially growing BHK21 cells were treated with calyculin A for...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nakamura K,Antoku S

    更新日期:1994-04-15 00:00:00

  • PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.

    abstract::We show here that PRL-3 protein is expressed in fetal heart, developing blood vessels, and pre-erythrocytes but not in their mature counterparts. These observations imply that PRL-3 may be involved in the early development of the circulatory system. Because PRL-3 mRNA had been reported to be consistently elevated in m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0726

    authors: Guo K,Li J,Wang H,Osato M,Tang JP,Quah SY,Gan BQ,Zeng Q

    更新日期:2006-10-01 00:00:00

  • Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.

    abstract::A significant impediment to the success of cancer chemotherapy is multidrug resistance (MDR). A typical form of MDR is attributable to the overexpression of membrane transport proteins, such as P-glycoprotein, resulting in an increased drug efflux. In this study, we show that adenovirus-mediated enhancement of the c-J...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1779

    authors: Zhou J,Liu M,Aneja R,Chandra R,Lage H,Joshi HC

    更新日期:2006-01-01 00:00:00

  • Production of human hematopoietic survival and growth factor by a myeloid leukemia cell line (KPB-M15) and placenta as detected by a monoclonal antibody.

    abstract::Fifty-five hematopoietic cell lines, including 19 T-, 16 B-, 5 pre-B-, 5 non-T non-B-, 1 erythroid, and 9 myeloid-monocytoid cells, were screened for production of human hematopoietic survival and stem cell growth factor (SCGF) by enzyme immunoassay using anti-SCGF monoclonal antibody. The KPB-M15 myeloid cell line co...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hiraoka A,Ohkubo T,Fukuda M

    更新日期:1987-10-01 00:00:00

  • Antigenicity of human T-cell leukemia virus-associated gp52: greater response in leukemia patients compared to healthy donors exposed to the virus.

    abstract::Monoclonal antibody HT462 recognizes a human T-cell leukemia virus type I (HTLV-I)-associated Mr 52,000 glycoprotein (HA-gp52), which is found on the surface of HTLV-infected cells. Whether HA-gp52 is encoded by the virus or by the infected cells has not yet been established. Using monoclonal HT462 in a competitive bi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Robert-Guroff M,Clark JW

    更新日期:1985-07-01 00:00:00

  • Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression.

    abstract::We have investigated the effect of partial hepatectomy (HEP) on tumor growth. MH-134 hepatoma cells, which were inoculated in syngeneic C3H/He mice from 3 to 10 days after HEP, grew with a linear increase in size until 7 days, began to regress, and disappeared 14 days after the inoculation. The survival rate was 100%,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ono M,Tanaka N,Orita K

    更新日期:1986-10-01 00:00:00

  • Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.

    abstract::To identify CpG islands differentially methylated in pancreatic adenocarcinoma, we used methylated CpG island amplification (MCA) coupled with representational difference analysis. Of 42 CpG islands identified by MCA/representational difference analysis, 7 CpG islands [methylated in carcinoma of the pancreas (MICP)] w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ueki T,Toyota M,Skinner H,Walter KM,Yeo CJ,Issa JP,Hruban RH,Goggins M

    更新日期:2001-12-01 00:00:00

  • Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of 1-aryl-3-alkyltriazenes.

    abstract::A series of arylalkyltriazenes has been investigated for its differential cytotoxicity towards the HT-29 (Mer+) and BE (Mer-) cell lines and for its ability to cause DNA strand breaks and cross-links. A monomethyltriazene (MMPT) and some hydroxymethyltriazene derivatives capable of generating the monomethyltriazene in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gibson NW,Hartley JA,LaFrance RJ,Vaughan K

    更新日期:1986-10-01 00:00:00

  • Flow cytometric detection of drugs altering the DNA methylation pattern.

    abstract::We have developed a model system for assessing the demethylating potential of external agents. Disruption in the DNA methylation pattern was evaluated at the translational level of the Escherichia coli beta-galactosidase coding gene (lacZ). We have constructed a clonal cell line (A4/4 cells) derived from the adenoviru...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Biard DS,Maratrat M,Thybaud V,Melcion C,Sarasin A

    更新日期:1992-10-01 00:00:00

  • Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.

    abstract::The expression of defects in the control of cellular differentiation is thought to be of etiological significance in the early stages of carcinogenesis. This possibility is supported by a variety of experimental studies including those that have established that metaplastic changes in cells can represent preneoplastic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sparks RL,Seibel-Ross EI,Wier ML,Scott RE

    更新日期:1986-10-01 00:00:00

  • Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.

    abstract::A potent modifying locus of intestinal tumorigenesis in the mouse was recently identified as secretory phospholipase A2 (sPLA2). The human homologue of sPLA2 maps to chromosome 1p35, a region frequently lost in human tumors. To evaluate the possibility that sPLA2 was a tumor suppressor gene that was the target of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Riggins GJ,Markowitz S,Wilson JK,Vogelstein B,Kinzler KW

    更新日期:1995-11-15 00:00:00

  • Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor.

    abstract::Melanoma-derived lipoprotein lipase inhibitor (MLPLI) is a factor purified from the conditioned medium of a human melanoma cell line, SEKI, which induced severe cachexia in tumor-bearing nude mice. Amino acid sequencing revealed that the amino-terminal portion was identical to that of leukemia-inhibitory factor (LIF)....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mori M,Yamaguchi K,Honda S,Nagasaki K,Ueda M,Abe O,Abe K

    更新日期:1991-12-15 00:00:00

  • Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line.

    abstract::A new human myeloma cell line, OPM-6, was established from the peripheral blood of a patient with advanced IgG-kappa plasma cell leukemia. Cytogenetic and phenotypic analysis confirmed that the cells were derived from the patient's leukemic cells. Insulin-like growth factor-1 (IGF-1) acts as an autocrine growth factor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ogawa M,Nishiura T,Oritani K,Yoshida H,Yoshimura M,Okajima Y,Ishikawa J,Hashimoto K,Matsumura I,Tomiyama Y,Matsuzawa Y

    更新日期:2000-08-01 00:00:00

  • Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.

    abstract::In eight estrogen receptor (ER)-positive breast cancer cell lines (including three sublines of MCF-7) and five ER-negative breast lines, the action of the nonsteroidal antiestrogen, tamoxifen, was studied, and the concentrations of ER and antiestrogen binding site were measured. The concentration of antiestrogen bindi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reddel RR,Murphy LC,Hall RE,Sutherland RL

    更新日期:1985-04-01 00:00:00

  • CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.

    abstract::Traditional chemotherapeutic drugs are often restricted by severe side effects and lack of tumor specificity. Peptide prodrugs cleavable by peptidases present in the tumor environment have been explored to improve the therapeutic index of cytotoxic drugs. One such prodrug of doxorubicin (Dox), CPI-0004Na [N-succinyl-b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pan C,Cardarelli PM,Nieder MH,Pickford LB,Gangwar S,King DJ,Yarranton GT,Buckman D,Roscoe W,Zhou F,Salles A,Chen TH,Horgan K,Wang YH,Nguyen T,Bebbington CR

    更新日期:2003-09-01 00:00:00